MHC class II presentation of FVIII-AnnexinA5 fusion proteins internalized by antigen presenting cells
IntroductionThe development of neutralizing antibodies (inhibitors) against coagulation factor VIII (FVIII) remains the most serious complication in the treatment of hemophilia A. While immune tolerance induction (ITI) is the standard strategy to elimi…